NO SET ASIDE USED.

LOVELACE BIOMEDICAL RESEARCH INSTITUTE - STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.

PIID: 75F40119C10161Solicitation ID: FDA19SOL1207956
Signed Date: Sep 26, 2019Effective Date: Sep 26, 2019End Date: Closed on Jun 30, 2025
Award $
$38.8M
Vendor
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
NAICS
541380
Signed Date
Sep 26, 2019

Key Details

Dollars Obligated
$38.8M
Base & All Options
$38.8M
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
SILVER SPRING, MD

Description

STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.

Context & Analysis

On Sep 26, 2019, Department of Health and Human Services obligated $38,812,828.5 to LOVELACE BIOMEDICAL RESEARCH INSTITUTE for study of e-cigarette aerosol toxicity in in vivo nonclinical models.. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SILVER SPRING, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.

Contractor Information

UEI: MBT9RXJJ7428
Location: ALBUQUERQUE, NM

Stay Updated

Get notified about new opportunities matching your interests.

Related